12.41 pm | 23 May 2013 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1250 in its May 21, 2013 research repor...

2.23 pm | 22 May 2013 |  Source: CNBC-TV18

Bino Pathiparampil of IIFL Capital told CNBC-TV18 that there has been a major rally in the sector over the last couple of years. Thus, many of the sto...

7.06 pm | 21 May 2013 |  Source: CNBC-TV18

Sharmila Joshi, Head of Equity of Peerless Securities expects more weakness in Divis Laboratories. The stock may lose another 3-4 percent from here on...

5.55 pm | 21 May 2013 |  Source: Moneycontrol.com

Divis Laboratories has reported a sales standalone turnover of Rs 651.28 crore and a net profit of Rs 181.83 crore for the quarter ended Mar '13...

2.40 pm | 21 May 2013 |  Source: CNBC-TV18

Aashish Tater of FortuneWizard.com is bearish on IFCI, Voltas and Divis Laboratories. He recommended selling these stocks....

11.05 am | 21 May 2013 |  Source: Moneycontrol.com

Disappointing fourth quarter earnings dragged Divis Laboratories 6 percent lower Tuesday. Consolidated net profit fell by 16.75 percent year-on-year t...

9.15 am | 21 May 2013 |  Source: CNBC-TV18

Aashish Tater of FortuneWizard.com advised going long in Crompton Greaves with a target price of Rs 106 and going short in Divis Labs with a target pr...

8.49 am | 21 May 2013 |  Source: CNBC-TV18

Valecha Engineering | Hotel Leela | Shriram City Union | IFCI | Divis Labs | Bayer CropScience | IG Petrochemicals | JSW Energy | Reliance Infrastruct...

9.16 pm | 20 May 2013 |  Source: PTI

Divi's Lab posted a net profit of Rs 216.91 crore in the same period of previous fiscal. Net sales of the company stood at Rs 655.83 crore for the fou...

7.00 pm | 20 May 2013 |  Source: Moneycontrol.com

Divis Laboratories has informed BSE that Prof. C. Ayyanna, Independent Director of the Company has resigned from the Board due to personal reasons and...

3.26 pm | 15 May 2013 |  Source: CNBC-TV18

Parag Doctor of Keynote Capital is bullish on Divis Laboratories, UCO Bank, Zee Entertainment and has recommended buy rating on the stocks, while he m...

11.51 am | 15 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com feels that a new uptrend seems to be starting in Ranbaxy Laboratories....

8.29 am | 15 May 2013 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com has recommended buy rating on Sun Pharma Advanced Research Company, Autoline Industries, Sonata Software and Reliance Co...

11.53 am | 14 May 2013 |  Source: CNBC-TV18

One can take a long position in Divis Laboratories. It is likely to outperform, says Sudarshan Sukhani of s2analytics.com....

11.29 am | 11 May 2013 |  Source: Moneycontrol.com

Divis Laboratories board meeting will be held on May 20, 2013, to consider and approve the audited financial results for the year ended March 31, 2013...

2.27 pm | 30 Apr 2013 |  Source: CNBC-TV18

In CNBC-TV18's popular show Bull's Eye, Nooresh Merani of AMSEC Research shares his trading strategies for the day....

9.39 am | 30 Apr 2013 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

12.39 pm | 29 Apr 2013 |  Source: CNBC-TV18

In CNBC-TV18's popular show Bull's Eye, Nooresh Merani, AMSEC Research shares his trading strategies for the day....

9.02 am | 29 Apr 2013 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

12.12 pm | 18 Apr 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com advised buying Divis Laboratories. According to him, pharmaceutical sector still outperforms....